City

Boston (1)

Miami (1)

New York (1)

Palo Alto (1)

Philadelphia (1)

Portland (1)

Saint Louis (1)

Seattle (1)

Overall Status

Active, not recruiting (2)

Phase

phase 1 (1)

phase 2 (1)

Sponsor

National Cancer Institute (NCI) (1)

OHSU Knight Cancer Institute (1)

Collaborator

Novartis Pharmaceuticals (1)

Oregon Health and Science University (1)

Intervention

laboratory biomarker analysis (2)

doxorubicin hydrochloride (1)

interferon gamma-1b (1)

pembrolizumab (1)

pharmacological study (1)

ribociclib (1)

Study Documents

Intervention Type

other (2)

biological (1)

drug (1)

Funder Type

NIH (1)

Other (1)

Study Type

Interventional (2)

unresectable synovial sarcoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma, Locally Advanced Leiomyosarcoma Trial in Portland (Doxorubicin

Active, not recruiting

Advanced Soft Tissue Sarcoma
+26 more

Doxorubicin Hydrochloride
+3 more

Portland, Oregon

OHSU Knight Cancer Institute

Jan 6, 2023

Metastatic Myxoid Liposarcoma, Metastatic Round Cell Liposarcoma, Metastatic Synovial Sarcoma Trial in United States (Interferon

Active, not recruiting

Has Results

Metastatic Myxoid Liposarcoma
+15 more

Interferon Gamma-1b
+2 more

Palo Alto, California
+6 more

Aug 2, 2022